Needham & Company LLC Reaffirms "Buy" Rating for EverQuote (NASDAQ:EVER)

Key Points

• Needham reaffirmed a "Buy" on EverQuote with a $25 price target (implying ~71% upside), while the analyst consensus is a "Moderate Buy" with an average target of $23.83.
• EverQuote beat Q1 expectations — $0.51 EPS vs. $0.43 and $190.9M revenue vs. $180.1M (revenue +14.6% YoY) — and guided Q2 revenue to $185–195M while reiterating a ~ $1B revenue target in 2–3 years.
• Despite the strong quarter, the stock trades below its 200‑day moving average near its 12‑month low, presenting technical/valuation risk, and insiders have been net sellers recently (insiders own 25.52%) amid ~91.5% institutional ownership.

EverQuote (NASDAQ:EVER - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $25.00 target price on the stock. Needham & Company LLC's price objective would indicate a potential upside of 71.12% from the stock's previous close.

Several other brokerages have also issued reports on EVER. Craig Hallum reissued a "buy" rating and issued a $20.00 price target on shares of EverQuote in a report on Tuesday, February 24th. B. Riley Financial reduced their price target on shares of EverQuote from $36.00 to $30.00 and set a "buy" rating on the stock in a research report on Tuesday, February 24th. JPMorgan Chase & Co. cut their target price on shares of EverQuote from $32.00 to $22.00 and set an "overweight" rating for the company in a research note on Tuesday, February 24th. Canaccord Genuity Group decreased their price target on EverQuote from $33.00 to $28.00 and set a "buy" rating on the stock in a research report on Tuesday, February 24th. Finally, Raymond James Financial reiterated an "outperform" rating and issued a $18.00 price objective on shares of EverQuote in a research report on Tuesday, February 17th. Six investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $23.83.

EverQuote Stock Up 0.8%

Shares of EVER opened at $14.61 on Tuesday. The stock's 50-day moving average price is $15.85 and its 200 day moving average price is $20.79. The firm has a market capitalization of $526.40 million, a price-to-earnings ratio of 5.53 and a beta of 0.56. EverQuote has a 12-month low of $13.88 and a 12-month high of $28.73.

EverQuote (NASDAQ:EVER - Get Free Report) last announced its quarterly earnings data on Monday, May 4th. The company reported $0.51 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.08. The company had revenue of $190.85 million during the quarter, compared to the consensus estimate of $180.10 million. EverQuote had a return on equity of 57.65% and a net margin of 14.34%.The company's quarterly revenue was up 14.6% on a year-over-year basis. During the same quarter last year, the company earned $0.21 EPS. Equities research analysts expect that EverQuote will post 1.91 EPS for the current year.

Insiders Place Their Bets

In other news, CAO Jon Ayotte sold 1,730 shares of the business's stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $15.56, for a total transaction of $26,918.80. Following the completion of the transaction, the chief accounting officer owned 86,202 shares of the company's stock, valued at approximately $1,341,303.12. The trade was a 1.97% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jayme Mendal sold 14,360 shares of the company's stock in a transaction on Friday, February 20th. The stock was sold at an average price of $14.98, for a total value of $215,112.80. Following the sale, the chief executive officer owned 541,777 shares of the company's stock, valued at approximately $8,115,819.46. This represents a 2.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 18,095 shares of company stock worth $272,489. 25.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in EVER. Royal Bank of Canada increased its position in EverQuote by 1,705.9% during the 1st quarter. Royal Bank of Canada now owns 65,428 shares of the company's stock worth $1,713,000 after purchasing an additional 61,805 shares in the last quarter. Amundi acquired a new stake in EverQuote in the first quarter valued at approximately $290,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of EverQuote by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,007 shares of the company's stock worth $393,000 after buying an additional 624 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of EverQuote by 615.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 339,672 shares of the company's stock valued at $8,896,000 after acquiring an additional 292,172 shares during the last quarter. Finally, Creative Planning boosted its stake in shares of EverQuote by 32.4% during the second quarter. Creative Planning now owns 10,526 shares of the company's stock valued at $255,000 after purchasing an additional 2,576 shares in the last quarter. Institutional investors own 91.54% of the company's stock.

Key Stories Impacting EverQuote

Here are the key news stories impacting EverQuote this week:

• Positive Sentiment: Q1 beat — EverQuote reported EPS of $0.51 vs. consensus $0.43 and revenue of $190.9M vs. $180.1M expected; revenue was up ~14.6% year‑over‑year and margins/ROE were strong. Press Release
• Positive Sentiment: Raised near-term revenue outlook — Company gave Q2 revenue guidance of $185M–$195M, above consensus (~$180.5M), signaling continuing top-line momentum. Guidance Article
• Positive Sentiment: Longer‑term growth target — Management reiterated a target of roughly $1B in revenue within 2–3 years, which supports a higher growth multiple if execution continues. Guidance Article
• Neutral Sentiment: Market reaction coverage — Media noted the jump in the stock (reported ~19% in some outlets) as investors digested the beat and guidance. This reflects short‑term momentum but not necessarily sustained outperformance. MSN Coverage
• Neutral Sentiment: Earnings call & materials available — Full Q1 call transcript and slide deck published; useful for investors reviewing unit economics and channel performance. Earnings Call Transcript
• Neutral Sentiment: Analyst / media writeups dissect metrics — Zacks and other outlets reviewed key metrics (customer acquisition, conversion KPIs) that matter for forward growth — read for nuance on sustainability. Zacks Analysis
• Neutral Sentiment: Comparative coverage — Industry comparisons (e.g., vs. Hippo) appeared, highlighting competitive dynamics in insurtech that investors should monitor. Comparative Article
• Negative Sentiment: Technical/valuation risks remain — Despite the beat, EVER is trading below its 200‑day average and nearer its 12‑month low, signaling potential longer‑term resistance and that investors should weigh execution risk against the upbeat guidance.

EverQuote Company Profile

EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.

The company's core business centers on a quote-comparison engine for personal auto, home, and health insurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.